Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2026
Shariska Harrington, MD
Defining and Targeting Epigenetic Vulnerabilities in Copy Number High Endometrial Cancer
Read More
2026
Natividad Fuentes, Jr., PhD
Harnessing membrane dynamics to enhance antitumor immunity
Read More
2026
Andrea Comba, PhD
Dissecting the Tumor-Brain Astrocyte Paracrine Crosstalk to Overcome Glioblastoma Progression
Read More
2026
Nam Woo Cho, MD, PhD
Breaking down the communication barrier to CAR-T cells using radiation
Read More
2026
Krystle Lang Kuhs, PhD, MPH
Accelerating viral biomarkers of oropharyngeal cancer prognosis
Read More
2026
Carman Li, PhD
Uncovering actionable epigenetic drivers of the early stage of basal-like breast cancer...
Read More
2026
Maralice Conacci-Sorrell, PhD
Harness Nucleolar Hypertrophy as a Therapeutic Vulnerability in HCC
Read More
2026
Juan Osorio, MD
Engineering Functional Immune Hubs in Cold Tumors through Myeloid Reprogramming
Read More
2026
Fernando Camargo, PhD
Targeting Hippo-YAP Dependencies in Hepatoblastoma
Read More
2026
Andrei Thomas-Tikhonenko, PhD
Ancestry-guided adoptive immunotherapy for pediatric T-cell leukemia
Read More
2026
Berkley Gryder, PhD
Targeting Enhancer Addiction in Fusion-Positive Rhabdomyosarcoma
Read More
2026
Riaz Gillani, MD
Dissecting the causes and consequences of tumor cell plasticity in osteosarcoma for...
Read More
2026
Sathish Padi, PhD
Targeting PP2A-MYC Regulatory Mechanisms in High-Risk Pediatric Cancers
Read More
2025
Sita Kugel, PhD
Targeting CDK7 in Patients with Resectable or Borderline Resectable Basal-Like Pancreatic Ductal...
Read More
2025
Erin George, MD
Controlling treatment toxicity in ovarian cancer to prime the patient for tumor...
Read More
2025
Kate Markey, MBBS, PhD
Defining microbial control of immune recovery after cancer treatment
Read More